Nicole Murphy Biogen Inc. (BIIB) insider trading activity

BIIB Quotes by TradingView

Nicole Murphy is Head of Pharm Ops and Tech of BIOGEN INC.. Currently has a direct ownership of 14,055 shares of BIIB, which is worth approximately $1.81 Million. The most recent transaction as insider was on Feb 18, 2022, when has been sold 110 shares (Common Stock) at a price of $209.79 per share, resulting in proceeds of $23,077. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.1K
0% 3M change
45.89% 12M change
Total Value Held $1.81 Million

Nicole Murphy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2022
SELL
Payment of exercise price or tax liability
$23,077 $209.79 p/Share
110 Reduced 6.23%
1,657 Common Stock
Feb 18 2022
BUY
Exercise of conversion of derivative security
-
371 Added 17.35%
1,767 Common Stock
Feb 12 2022
SELL
Payment of exercise price or tax liability
$19,742 $214.59 p/Share
92 Reduced 6.18%
1,396 Common Stock
Feb 12 2022
BUY
Exercise of conversion of derivative security
-
263 Added 15.02%
1,488 Common Stock
NM

Nicole Murphy

Head of Pharm Ops and Tech
Cambridge, MA

Track Institutional and Insider Activities on BIIB

Follow BIOGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

News

Receive news related to BIOGEN INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BIIB